文献速递心外重症与机械循环支持

心脏移植术后血管麻痹:独立血流动力学表型及其临床后果

Vasoplegia as a distinct hemodynamic phenotype after heart transplantation: Prevalence, determinants, and clinical consequences despite preserved allograft function.
PubMed 文献 · J Thorac Cardiovasc Surg · 2026-05-14

本研究为单中心回顾性队列,纳入2020至2025年488例孤立心脏移植成人,排除中重度原发性移植物功能障碍或心指数持续<2.2 L/min/m²者。术后24小时内血管麻痹发生率为17.4%,独立预测因素包括男性、术前左心室辅助装置支持、较高肌酐、较长移植物缺血时间及体外循环时间。血管麻痹与机械通气延长、肾脏替代治疗需求、出院时持续透析及30天和90天死亡率增加独立相关。

要点

  • 心脏移植术后血管麻痹发生率17.4%,独立于移植物功能。
  • 预测因素包括男性、术前LVAD、高肌酐、长缺血及体外循环时间。
  • 血管麻痹与肾损伤、通气延长及死亡风险增加独立相关。

核心结论

  • 血管麻痹是心脏移植术后常见的高危血流动力学表型,与肾脏功能障碍、资源使用增加和死亡率相关,支持常规监测和针对性预防。

研究设计与样本

  • 单中心回顾性队列研究,纳入2020至2025年488例接受孤立心脏移植的成人,排除中重度原发性移植物功能障碍或心指数<2.2 L/min/m²持续24小时者。
  • 提取术后48小时每小时血流动力学和去甲肾上腺素当量剂量,采用弹性网回归结合Firth重拟合识别预测因素,并利用逆概率治疗加权估计独立关联。

主要发现

  • 血管麻痹发生于488例中的85例(17.4%)。
  • 独立预测因素包括男性、术前左心室辅助装置支持、较高术前肌酐、较长移植物缺血时间和较长体外循环时间(模型AUC 0.74)。
  • 逆概率治疗加权后,血管麻痹仍独立关联机械通气延长(+4.2小时)、肾脏替代治疗几率增加(OR 2.72)、出院时持续血液透析(OR 2.97)以及30天和90天死亡率增加(均P < .05)。
  • 三级分析中,持续性血管麻痹(≥12小时)的肾损伤负担、通气延长和1年死亡率最高。

关键数值与推荐

  • 血管麻痹定义:术后24小时内同时满足平均动脉压<65 mm Hg、全身血管阻力<800 dyn s cm⁻⁵、心指数≥2.2 L/min/m²、去甲肾上腺素当量剂量≥0.2 μg/kg/min。
  • 二级表型按48小时内持续时间分为无、短暂性和持续性血管麻痹。

临床怎么用

  • 对心脏移植术后患者应常规评估血管麻痹表型,尤其存在男性、术前LVAD、高肌酐、长缺血或体外循环时间等风险因素时。
  • 识别血管麻痹有助于预警肾损伤、延长通气和死亡风险,可能指导针对性预防和资源分配。

局限性

  • 单中心回顾性设计可能限制普遍性。
  • 排除中重度原发性移植物功能障碍和低心指数患者,结论不适用于该人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vasoplegia is a recognized complication of cardiopulmonary bypass, yet its prevalence and clinical impact after heart transplantation (HT) remain incompletely defined, particularly when primary graft dysfunction is excluded. This study aims to characterize posttransplant vasoplegia using a consensus-based framework, identify perioperative risk factors, and quantify its impact on posttransplant outcomes. METHODS: We conducted a single-center retrospective cohort study of 488 adults undergoing isolated HT between 2020 and 2025. Patients with moderate/severe primary graft dysfunction or cardiac index <2.2 L/min/m2 for 24 hours were excluded. Hourly hemodynamics and norepinephrine-equivalent dose were extracted for 48 hours. Vasoplegia was defined by concurrent hypotension (mean arterial pressure <65 mm Hg), low systemic vascular resistance (<800 dyn s cm-5), preserved cardiac index (≥2.2 L/min/m2), and elevated norepinephrine-equivalent dose (≥0.2 μg/kg/min) within the first 24 hours. A secondary 3-level phenotype (none, transient, sustained) was defined by duration over 48 hours. Elastic net regression with Firth refitting identified predictors. Inverse probability of treatment weighting was used to estimate the independent association of vasoplegia with postoperative outcomes. RESULTS: Vasoplegia occurred in 85 of 488 patients (17.4%). Independent predictors included male sex, pretransplant left ventricular assist device support, greater pretransplant creatinine, longer allograft ischemic time, and prolonged cardiopulmonary bypass duration (model area under the curve, 0.74). After inverse probability of treatment weighting, vasoplegia remained independently associated with longer mechanical ventilation (+4.2 hours), greater odds of renal-replacement therapy (odds ratio, 2.72), requirement for ongoing hemodialysis at discharge (odds ratio, 2.97), and increased 30- and 90-day mortality (all P < .05). In the 3-level analysis, sustained vasoplegia (≥12 hours) demonstrated the greatest burden of renal injury, prolonged ventilation, and 1-year mortality. CONCLUSIONS: Vasoplegia is frequent after HT, defines a high-risk phenotype, and is linked to renal dysfunction, prolonged resource use, and mortality, supporting its routine measurement and targeted prevention.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Ahmad A, Wang CC, Williams AM, et al. Vasoplegia as a distinct hemodynamic phenotype after heart transplantation: Prevalence, determinants, and clinical consequences despite preserved allograft function. J Thorac Cardiovasc Surg. 2026. PMID: 42140552. doi:10.1016/j.jtcvs.2026.04.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。